Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Investigational new drug/clinical

Investigational New Drug/Clinical Trial Application Stage Phase II and Phase III Studies... [Pg.387]

With these preclinical toxicology and biocompatibility studies carried out in animals having demonstrated both the efficacy and safety of the polyanhydrides, studies involving these materials moved toward human clinical use. In 1987, the Food and Drug Administration approved experimental use of these polyanhydrides in humans, under an Investigational New Drug clinical trial application. A Phase I/II clinical trial of 21 patients in five U.S. hospitals was carried out... [Pg.137]

Requests for permission to conduct clinical trials with pharmaceuticals in the US are termed Investigational New Drug Applications (INDs). The applications are actually a request for an exemption to supply a drug without a marketing authorisation. A cover sheet (Form 1571) must accompany the application. This cover sheet should also be used with each subsequent communication with the FDA, with each form consecutively numbered, starting at 000 for the initial submission. A copy of the form is shovm in Figure 5.6. [Pg.89]

AIDSTRIALS (AIDS Clinical Trials). The AIDSTRIALS database [80] provides information about AIDS-related studies of experimental treatments conducted under the FDA s investigational new drug (IND) regulations. AIDSTRIALS contains information about clinical trials of agents undergoing evaluation for use against AIDS, HIV infection, and AIDS-related opportunistic diseases such as Pneumocystis carinii pneumonia (PCP). Detailed information is supplied... [Pg.776]

After completing preclinical testing, a company files an Investigational New Drug (IND) application with the regulators (the FDA in the U.S.), so that clinical studies in man can begin. The IND shows results of all experiments to this point, a detailed proposal for the clinical study, the expected mode of action for the drug, and any side effects observed. All clinical trials will also be reviewed and approved by the Institutional Review Board (IRB) at the clinic where the trials will be run. [Pg.91]

An investigational new drug is a new chemical-based, biologic or biopharmaceutical substance for which the FDA has given approval to undergo clinical trials. An IND application should contain information detailing preclinical findings, method of product manufacture and proposed protocol for initial clinical trials (Table 4.9). [Pg.92]

Estimation of Initial Safety and Tolerability. The initial and subsequent administration of an investigational new drug into humans is usually intended to determine the tolerability of the does range expected to be needed for later clinical studies and to determine the nature of adverse reactions that can be expected. These studies typically include both single and multiple dose administration. [Pg.782]

Pharmaceutical firms have to reexamine their strategies to devise means to increase their drug pipelines for continuous streams of products. The high failure rates of Investigational New Drugs during clinical trials (see Exhibit 5.8) necessitate the development of better assay systems and animal models that correlate closely with human pharmacodynamics and pharmacokinetics. The study of pharmacogenomics will be crucial to address this issue. [Pg.386]


See other pages where Investigational new drug/clinical is mentioned: [Pg.22]    [Pg.123]    [Pg.22]    [Pg.123]    [Pg.328]    [Pg.152]    [Pg.101]    [Pg.3]    [Pg.235]    [Pg.173]    [Pg.337]    [Pg.282]    [Pg.92]    [Pg.328]    [Pg.328]    [Pg.349]    [Pg.322]    [Pg.196]    [Pg.196]    [Pg.189]    [Pg.3]    [Pg.38]    [Pg.38]    [Pg.64]    [Pg.773]    [Pg.11]    [Pg.327]    [Pg.247]    [Pg.277]    [Pg.292]    [Pg.474]    [Pg.523]    [Pg.559]    [Pg.576]    [Pg.137]    [Pg.187]    [Pg.211]    [Pg.232]    [Pg.322]    [Pg.147]   


SEARCH



Clinical drugs

Clinical investigations

Clinical investigators

Drugs, new

© 2024 chempedia.info